Courtroom Epistemology: When Vaccine Litigation Became the Arbiter of Scientific Truth
The Courtroom as Epistemic Arena
When a federal judge instructs a jury to weigh competing expert testimonies about vaccine-related injury, something philosophically significant is occurring that extends well beyond the immediate question of damages. A legal proceeding, governed by rules of evidence that were never designed with scientific methodology in mind, is determining what counts as credible knowledge about biological causation. The verdict may settle a case, but the evidentiary standards that shaped it do not quietly retire when the gavel falls.
American vaccine litigation—particularly the wave of cases that passed through the National Vaccine Injury Compensation Program (VICP) after its creation in 1986, and the subsequent Omnibus Autism Proceedings that concluded in 2009—offers one of the most instructive case studies in modern science studies. These proceedings did not merely adjudicate disputes; they constructed, refined, and in some instances legitimized alternative frameworks for evaluating scientific claims. Understanding how this happened requires attending carefully to the structural differences between legal and scientific epistemologies, and to the historical moments at which those differences became consequential.
Two Systems of Validation
Scientific knowledge, in the tradition most American researchers are trained to inhabit, acquires credibility through a recognizable set of practices: experimental replication, peer review, statistical significance thresholds, and the slow accumulation of consensus within a community of qualified practitioners. The process is neither neutral nor infallible—as the history and philosophy of science has long demonstrated—but it does carry internal mechanisms for self-correction that operate across time and institutional boundaries.
Legal epistemology works differently. Courts do not wait for consensus; they require decisions within defined timeframes. The adversarial structure of American litigation means that for every credentialed expert affirming a causal link, an opposing party may produce an equally credentialed expert denying it. The Daubert standard, established by the Supreme Court in 1993 and subsequently refined in Joiner (1997) and Kumho Tire (1999), tasked federal judges with serving as gatekeepers for expert scientific testimony—a responsibility that placed non-specialists in the position of evaluating methodological adequacy without the disciplinary training to do so reliably.
What emerged from this arrangement was not simply a legal mechanism for filtering bad science. It was, effectively, a parallel system of validation, one capable of certifying scientific claims that the mainstream research community had not endorsed, or of casting doubt on claims it had.
Discovery, Deposition, and the Manufacture of Uncertainty
The legal discovery process has proven particularly consequential in reshaping the epistemic landscape surrounding vaccines. When plaintiffs' attorneys subpoena internal communications from pharmaceutical manufacturers or regulatory agencies, they gain access to documents that were never intended for public scientific scrutiny. Preliminary research findings, abandoned hypotheses, internal disagreements among scientists, and cautiously worded safety assessments can all be introduced into legal proceedings as evidence of concealed risk—regardless of whether the underlying science supports that inference.
This dynamic has a well-documented history in American tort litigation. The tobacco industry's internal documents, made public through litigation in the 1990s, genuinely revealed suppressed evidence of harm. That precedent established a culturally resonant template: corporate or governmental secrecy, when exposed through legal discovery, could be framed as scientific malfeasance. Applied to vaccine litigation, this template has sometimes generated the appearance of suppressed evidence where none existed, transforming internal scientific deliberation—the ordinary, necessary uncertainty of research in progress—into apparent confirmation of wrongdoing.
Expert witness testimony compounds this effect. The market for expert witnesses in vaccine injury cases has produced a cadre of credentialed professionals whose scientific conclusions, formed in the context of litigation rather than independent inquiry, carry institutional authority that lay audiences find difficult to distinguish from mainstream research consensus. A physician testifying about a proposed causal mechanism between a vaccine adjuvant and neurological injury may hold genuine academic credentials while advancing a hypothesis that has been thoroughly examined and rejected by the relevant scientific community. Inside the courtroom, the distinction is rarely legible.
Precedent as Epistemological Infrastructure
The outcomes of major vaccine litigation have done more than resolve individual claims. They have deposited precedents—legal, rhetorical, and institutional—that structure subsequent debates about scientific authority. When the Vaccine Court's Special Masters ruled in 2009 that the evidence did not support a causal link between the MMR vaccine and autism, the decision was scientifically sound and consistent with an overwhelming body of peer-reviewed research. Yet the proceedings themselves had already accomplished something irreversible: they had granted the causal hypothesis a formal arena, a structured legitimacy, and a public record that continued to circulate as evidence of a genuine scientific controversy.
This is not an argument that legal proceedings should exclude contested scientific questions. Courts must adjudicate disputes that touch on science whether or not science has reached resolution. The philosophical point is narrower: when legal processes become the primary public theater in which scientific disputes are staged, they inevitably reshape public understanding of what scientific controversy looks like and what resolves it.
Implications for Epistemic Authority
The longer-term consequence of vaccine litigation's influence on American scientific culture is a partial displacement of institutional scientific authority by legal authority. Peer review, once the recognized mechanism by which scientific claims earned credibility, now competes with judicial certification in the public imagination. A study published in a high-impact journal and a legal ruling that credits expert testimony about vaccine injury do not carry equivalent epistemic weight within the scientific community—but they may carry equivalent weight in public discourse, in legislative hearings, and in the policy environments where scientific consensus must be translated into collective action.
For historians and philosophers of science, this phenomenon demands sustained attention. The question is not whether courts are competent to evaluate scientific evidence—they demonstrably struggle with this task—but rather how the institutional encounter between legal and scientific epistemologies transforms both. American vaccine litigation has produced a case study of unusual richness and consequence: a domain in which the rules governing what counts as proof have been visibly, publicly, and consequentially contested, and in which the outcome of that contest continues to shape what American publics believe about biological risk, institutional trustworthiness, and the nature of scientific knowledge itself.
